drugset / Trial / NCT00141622

Sodium-Endothelial Function-CKD Study

NCT00141622 ↗

RandomizedCrossoverDouble-blindPrevention

Summary

Heart disease and stroke, known as cardiovascular disease, are major causes of death in people with chronic kidney disease. Abnormalities of a metabolic pathway called the "L-arginine-nitric oxide" pathway are thought to be particularly important in these people, and previous research in animals has suggested that sodium (salt) affects part of this metabolic pathway. The purpose of our research is to study the effects of sodium intake on the "L-arginine-nitric oxide" pathway, and on blood vessel function, in patients with kidney disease.

Timeline

Start
2005-04
Primary completion
—
Completion
2006-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Slow Sodium Unknown 150 mmol —